Genomic medicine and rare disease at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
54 organizations at FoG London 2027 present work in genomic medicine & rare disease: 26 NHS, government and non-profit bodies, 19 suppliers and service providers and 9 universities and research institutes. Between them they bring 94 presentations to the program. Most represented: University of Oxford, University of Edinburgh and The Institute of Cancer Research. As of Oct 29, 2026.
Format
Top represented
Showing 1–5 of 54 organizations
| Organization | FoG London 2027 Attendance |
|---|---|
University of Oxford Oxford, UK | |
Collegiate research university in Oxford, England, whose Medical Sciences Division spans human genetics, population health and clinical research. | Talk Wed Jan 27 11:30–12:00 Why Do We Sleep? Why animals evolved to sleep, how light and body clocks time it, and how shift work and jet lag disrupt health. Population & social genomics Talk Wed Jan 27 12:30–13:00 Sequence Data for Outbreak Intelligence: Gene-by-Gene Genomics and Population Annotation in Pathogen Surveillance Why tracking bacterial outbreaks needs gene-by-gene genome comparison rather than human genetics methods, shown through an outbreak of meningococcal disease in Kent. Talk Wed Jan 27 14:30–15:00 Design and Translation of Next Generation Delivery Vehicles for Advanced Therapeutics New ways to deliver advanced therapies, including pulsed and long-acting release systems, microrobots and new tools for measuring nanoparticles. Talk Wed Jan 27 14:30–15:00 Making AMR Diagnostics Work Where They Matter Most: Genomics, Sepsis and Sustainable Implementation Why tests for drug-resistant infections and newborn sepsis in low- and middle-income countries depend on cost and infrastructure, and how genomics tracks spread. Talk Wed Jan 27 16:30–17:00 Accelerating the Development of Therapies for Rare Genetic Disease How a transatlantic partnership brings expertise and investment to preclinical drug projects for rare genetic diseases. Talk Wed Jan 27 16:30–17:00 The AI Revolution After the Genome: How AI Is Inventing Genetically Enabled Medicines How genomic discoveries, national supercomputers and self-running laboratories are letting AI design new medicines based on genetics. Talk Wed Jan 27 16:30–17:00 The Body Clock in Your Blood: Circadian Signals in Omics Research How proteins and metabolites in one blood sample can reveal a person's body-clock time, and why time of day skews biomarker studies. Talk Wed Jan 27 17:30–18:00 Using Pathogen Genomics to Inform Vaccine Strategy and Public Health Response How international lab data on invasive bacterial disease track post-pandemic shifts in bacterial strains and what they mean for vaccines. Talk Thu Jan 28 11:30–12:00 Harnessing Bacterial Competition to Prevent Disease in the Gut Microbiome How finding the gut bacteria that best outcompete pathogens can guide the design of protective microbial mixtures. Talk Thu Jan 28 12:30–13:00 Deciphering Mammalian Morphogenesis - A Single-Cell Phenomic Perspective How tracking single cells' molecules, shape and behaviour in early mammalian embryos shows how the front end is patterned and the heart starts beating. Panel Thu Jan 28 14:10–14:40 Is Modern Life Fighting Our Human Biology? Whether modern food environments and inactive lifestyles clash with our evolved biology, and why genetics makes some people more prone to obesity. Population & social genomics Talk Thu Jan 28 14:10–14:40 Multimodal Liquid Biopsy for Early Cancer Detection: From Methylation to Single-Molecule Sequencing Why first-generation multi-cancer blood tests fall short, and how AI analysis of several features of tumour DNA in the blood could improve them. Talk Thu Jan 28 14:10–14:40 Quantum Computing & The Future of Genomic Data: From Single Genomes to Pangenomes How a virus genome encoded on a quantum computer points to new ways of analysing pangenomes, reference sets built from many genomes. Talk Thu Jan 28 14:10–14:40 Why Endometriosis Is Not One Disease: Insights from Genetics How large genetic studies split endometriosis into distinct subtypes, link it to ovarian and endometrial cancers and point to new treatment targets. Workshop Thu Jan 28 14:10–15:40 Making Sense of Multi-Omic Data: Scalable Analysis and Interpretation Multi-omics & proteomics Talk Thu Jan 28 14:40–15:10 Talk Thu Jan 28 15:10–15:40 Utilising Multi-omic Integration & Machine Learning for the Better Understanding of Disease: Painful and Painless Peripheral Neuropathy Example How combining genetic, gene expression, protein and metabolite markers could explain why only some people with nerve damage develop lasting pain. Panel Thu Jan 28 15:10–15:40 Why Does Disease Spare Some of Us? Why the same infection makes some people very ill and spares others, and how naturally resistant people could inspire new treatments. Population & social genomics Talk Thu Jan 28 16:10–16:40 Single-Cell & Spatial Multi-Omics to Decrypt Intestinal Development How a cell-by-cell map of the developing human gut tracks its maturation and why preterm birth may impair it. Workshop Thu Jan 28 16:10–17:10 From Variant to Action: A Hands-On Workshop to Reimagine Variant Interpretation Genomic medicine & rare disease Talk Thu Jan 28 16:40–17:10 Human in vivo Perturb Seq: New Insights into Human Inflammatory Disease How repeated tissue biopsies from treated patients, read cell by cell, reveal how drugs act on inflammatory diseases and why some stop working. Talk Thu Jan 28 16:40–17:10 Leveraging Big Data to Inform Cardiovascular Precision Medicine How combining genomic, clinical and real-world patient data can identify cardiovascular disease risk and guide more targeted prevention and treatment. |
University of Edinburgh Edinburgh, UK | |
Public research university in Edinburgh, Scotland, with a medical school, the Institute of Genetics and Cancer and the Roslin Institute for animal sciences. | Talk Wed Jan 27 11:30–13:00 Interactive Session: Building Trust in AI – Identifying Bias, Data Leakage and Hidden Failure Modes AI in drug discovery & diagnostics Talk Wed Jan 27 16:30–17:00 Four Nations Data Linkage in Longitudinal Research - Opportunities and Challenges What it takes to link long-running population studies across England, Scotland, Wales and Northern Ireland into richer research datasets. Talk Wed Jan 27 17:00–17:30 Beyond the Majority: Rethinking Treatment for Rare Ovarian Cancer Subtypes Why rarer ovarian cancer subtypes are understudied, and how genomic insights and newer drugs could improve their treatment. Talk Thu Jan 28 12:00–12:30 Using Epigenetic Signatures to Predict Ageing and Disease Risk How DNA methylation marks can estimate ageing and disease risk, and reveal effects of pollution, smoking and vaping in large cohorts. Talk Thu Jan 28 12:30–13:00 Developing a Clinically Useful Blood Test for Earlier Brain Tumour Diagnosis How a blood test using infrared light could catch brain tumours earlier, and what good diagnostic accuracy means in practice. Talk Thu Jan 28 14:10–14:40 3D Genome Organisation and Gene Regulation: Understanding the Non-Coding Genome How the three-dimensional folding of chromosomes brings distant control regions into contact with genes, and what this reveals about non-coding DNA. Panel Thu Jan 28 15:10–15:40 Why Does Disease Spare Some of Us? Why the same infection makes some people very ill and spares others, and how naturally resistant people could inspire new treatments. Population & social genomics Workshop Thu Jan 28 16:10–17:10 From Variant to Action: A Hands-On Workshop to Reimagine Variant Interpretation Genomic medicine & rare disease |
The Institute of Cancer Research London, UK | |
Cancer research institute and college of the University of London, working in partnership with The Royal Marsden. | Talk Wed Jan 27 12:30–13:00 Direct-to-Patient (DTP) Genetic Testing Pathways: Unlocking Capacity For The NHS Genomic Medicine Service and Genomic Population Health Service How offering genetic tests directly to patients could widen access while easing pressure on NHS genomic services. Talk Wed Jan 27 12:30–13:00 Polygenic Risk Scores for Prostate Cancer Risk Stratification - Lessons From the BARCODE1 Study How polygenic risk scores, which add up many small genetic effects, could better target prostate cancer screening and weigh the risk of overdiagnosis. Talk Wed Jan 27 14:30–15:00 MAVEs: Multiplex Assays of Functional Effect: Saying Goodbye To VUSs? How lab assays measuring the effects of thousands of genetic variants at once could settle uncertain variants in cancer genetic testing. Talk Wed Jan 27 14:30–15:00 Mapping the Invasive Tumour: How Spatial Biology is Revealing Cancer's Next Move How spatial biology, which maps cells where they sit in tissue, shows how tumour layout and support cells help cancer invade. Talk Wed Jan 27 15:30–16:00 Exploiting Genome Evolution in Inflammatory Bowel Disease to Prevent Colorectal Cancer How cells with abnormal chromosome numbers spread through the inflamed colon years before visible change, flagging future cancer risk in inflammatory bowel disease. Talk Thu Jan 28 11:30–12:00 Integrating Circulating Tumour DNA into Treating Head and Neck Cancer How testing tumour DNA in the blood can guide head and neck cancer treatment, both curative and palliative, and what challenges remain. |
NHS trust running St George's Hospital in Tooting, a south-west London teaching hospital with clinical genetics services. | Talk Wed Jan 27 15:30–16:00 Beyond the Diagnostic Odyssey: What Comes After Genomic Diagnosis? How whole-genome sequencing is diagnosing children with rare developmental disorders, and what it takes to move from diagnosis to targeted treatment. Talk Wed Jan 27 17:30–18:00 Genotype-Guided Antiplatelet Therapy in Acute Ischemic Stroke Why some stroke patients resist the anti-clotting drug clopidogrel, and the evidence for and barriers to genetic testing that guides treatment. Talk Thu Jan 28 14:10–15:40 Behind the Result, Beyond the Report: Collaborative Case Discussions on Genomic Testing Dilemmas from Different Perspectives Genomic medicine & rare disease Talk Thu Jan 28 16:40–17:10 From Research to Reality: Ensuring Women Benefit from Innovation How to design women's health tests and technologies that work for all women, and who risks being left behind by them. |
University of Manchester Manchester, UK | |
Public research university in Manchester, England, with a Faculty of Biology, Medicine and Health. | Talk Wed Jan 27 17:00–17:30 From One-Size-Fits-All to Personalised Cancer Screening How combining polygenic risk scores, family history and mammogram features could tailor cancer screening to each person's risk instead of age. Talk Wed Jan 27 17:30–18:00 Interoperable by Design: Building the Digital Infrastructure for Population Genomics How to build digital systems that let genomic data move between health software and give family doctors clear guidance on results. Talk Thu Jan 28 14:10–14:40 Designing Imaging AI for Clinical Translation from Day One How building medical imaging AI collaboratively, with representative data and regulatory needs in mind from the start, helps it reach the clinic. Talk Thu Jan 28 14:40–15:10 Decoding the Epigenome: Using Multi-Omics to Understand Cancer Cell States How machine learning helps decode epigenetic and RNA signals in cancer cells to define cancer subtypes and understand treatment response. |
Find buyers in genomic medicine & rare disease
Tell us what you sell and we’ll find the people at organizations working on genomic medicine & rare disease most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse FoG London 2027 by
Organization type
Topic
- Genomic medicine & rare disease 54
- Cancer genomics & diagnostics 31
- AI in drug discovery & diagnostics 43
- Biodata & bioinformatics 33
- Single-cell genomics 24
- Spatial biology 19
- Multi-omics & proteomics 31
- Epigenetics & translational omics 16
- Pharmacogenomics & patient stratification 16
- Women’s and children’s health 13
- Cell & gene therapy 18
- Microbiome & pathogen genomics 17
- Plant & agricultural genomics 13
- Population & social genomics 23
Exhibit hall
Everyone
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction